These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens. Ng WK; Chow JC; Ng PK Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. Abutaily AS; Addis BJ; Roche WR J Clin Pathol; 2002 Sep; 55(9):662-8. PubMed ID: 12194995 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Afify AM; al-Khafaji BM Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029 [TBL] [Abstract][Full Text] [Related]
5. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Di Loreto C; Puglisi F; Di Lauro V; Damante G; Beltrami CA Cancer Lett; 1998 Feb; 124(1):73-8. PubMed ID: 9500194 [TBL] [Abstract][Full Text] [Related]
6. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma. Bakir K; Koçer NE; Deniz H; Güldür ME Ann Diagn Pathol; 2004 Dec; 8(6):337-41. PubMed ID: 15614737 [TBL] [Abstract][Full Text] [Related]
7. Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Khoor A; Whitsett JA; Stahlman MT; Olson SJ; Cagle PT Hum Pathol; 1999 Jun; 30(6):695-700. PubMed ID: 10374779 [TBL] [Abstract][Full Text] [Related]
8. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Ordóñez NG Am J Surg Pathol; 2000 Apr; 24(4):598-606. PubMed ID: 10757409 [TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma. Klebe S; Swalling A; Jonavicius L; Henderson DW J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863 [TBL] [Abstract][Full Text] [Related]
10. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique. Jan IS; Chung PF; Weng MH; Huang MS; Lee YT; Kuo SH J Formos Med Assoc; 2006 Sep; 105(9):695-700. PubMed ID: 16959616 [TBL] [Abstract][Full Text] [Related]
11. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions. Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A Respirology; 2015 Jul; 20(5):831-3. PubMed ID: 25873201 [TBL] [Abstract][Full Text] [Related]
12. miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology. Cappellesso R; Galasso M; Nicolè L; Dabrilli P; Volinia S; Fassina A Cancer Cytopathol; 2017 Aug; 125(8):635-643. PubMed ID: 28449331 [TBL] [Abstract][Full Text] [Related]
13. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Bishop JA; Sharma R; Illei PB Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516 [TBL] [Abstract][Full Text] [Related]
14. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study]. Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300 [TBL] [Abstract][Full Text] [Related]
15. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma. Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485 [TBL] [Abstract][Full Text] [Related]
16. [Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma]. Xu X; Liu H; Jiang H; Li C; Yuan S; Yang J Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1610-3. PubMed ID: 26607085 [TBL] [Abstract][Full Text] [Related]
17. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid. Liu L; Cohen C; Siddiqui MT Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220 [TBL] [Abstract][Full Text] [Related]
18. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132 [TBL] [Abstract][Full Text] [Related]
19. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
20. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]